Haglund C - Search Results

1

Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.

Kauppila JH, Korvala J, Siirilä K, Manni M, Mäkinen LK, Hagström J, Atula T, Haglund C, Selander KS, Saarnio J, Karttunen TJ, Lehenkari PP, Salo T. Kauppila JH, et al. Among authors: haglund c. J Oral Pathol Med. 2015 Sep;44(8):571-7. doi: 10.1111/jop.12272. Epub 2014 Oct 23. J Oral Pathol Med. 2015. PMID: 25338738

2

Expression of cyclooxygenase-2 in human transitional cell carcinoma of the urinary bladder.

Ristimäki A, Nieminen O, Saukkonen K, Hotakainen K, Nordling S, Haglund C. Ristimäki A, et al. Among authors: haglund c. Am J Pathol. 2001 Mar;158(3):849-53. doi: 10.1016/S0002-9440(10)64033-3. Am J Pathol. 2001. PMID: 11238034 Free PMC article.

3

The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.

Paju A, Sorsa T, Tervahartiala T, Koivunen E, Haglund C, Leminen A, Wahlström T, Salo T, Stenman UH. Paju A, et al. Among authors: haglund c. Br J Cancer. 2001 May 18;84(10):1363-71. doi: 10.1054/bjoc.2001.1806. Br J Cancer. 2001. PMID: 11355948 Free PMC article.

4

Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma.

Atula T, Hedström J, Finne P, Leivo I, Markkanen-Leppänen M, Haglund C. Atula T, et al. Among authors: haglund c. Anticancer Res. 2003 May-Jun;23(3C):3051-6. Anticancer Res. 2003. PMID: 12926160

5

Tenascin-C in primary Merkel cell carcinoma.

Koljonen V, Jahkola T, Tukiainen E, Granroth G, Haglund C, Böhling T. Koljonen V, et al. Among authors: haglund c. J Clin Pathol. 2005 Mar;58(3):297-300. doi: 10.1136/jcp.2004.018432. J Clin Pathol. 2005. PMID: 15735164 Free PMC article.

6

Prognostic role of cyclooxygenase-2 in neoadjuvant-treated patients with squamous cell carcinoma of the esophagus.

Sivula A, Buskens CJ, van Rees BP, Haglund C, Offerhaus GJ, van Lanschot JJ, Ristimäki A. Sivula A, et al. Among authors: haglund c. Int J Cancer. 2005 Oct 10;116(6):903-8. doi: 10.1002/ijc.21134. Int J Cancer. 2005. PMID: 15856454 Clinical Trial.

7

Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.

Mrena J, Wiksten JP, Thiel A, Kokkola A, Pohjola L, Lundin J, Nordling S, Ristimäki A, Haglund C. Mrena J, et al. Among authors: haglund c. Clin Cancer Res. 2005 Oct 15;11(20):7362-8. doi: 10.1158/1078-0432.CCR-05-0764. Clin Cancer Res. 2005. PMID: 16243808

8

MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer.

Mrena J, Wiksten JP, Nordling S, Kokkola A, Ristimäki A, Haglund C. Mrena J, et al. Among authors: haglund c. J Clin Pathol. 2006 Jun;59(6):618-23. doi: 10.1136/jcp.2005.033761. J Clin Pathol. 2006. PMID: 16731602 Free PMC article.

9

Cyclooxygenase-2 expression in squamous cell carcinoma of the oral cavity and pharynx: association to p53 and clinical outcome.

Atula T, Hedström J, Ristimäki A, Finne P, Leivo I, Markkanen-Leppänen M, Haglund C. Atula T, et al. Among authors: haglund c. Oncol Rep. 2006 Sep;16(3):485-90. Oncol Rep. 2006. PMID: 16865247

10

Epithelial MMP-2 expression correlates with worse prognosis in pancreatic cancer.

Juuti A, Lundin J, Nordling S, Louhimo J, Haglund C. Juuti A, et al. Among authors: haglund c. Oncology. 2006;71(1-2):61-8. doi: 10.1159/000100988. Epub 2007 Mar 21. Oncology. 2006. PMID: 17377415

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

514 results

Search Page

Filters